Forbes contributors publish independent expert analyses and insights. I’m an analyst covering neurotech's impact on business and society. In 2019 Synchron was two years into a $10 million series A ...

Mark Jackson is playing a computer game with his mind. As he reclines in bed, three blue circles appear on a laptop screen a few feet away. One turns red: the target. Jackson is in control of a white ...

NEW YORK--(BUSINESS WIRE)--Synchron, an implantable brain-computer interface (BCI) company, today announced the medical journal JAMA Neurology has published peer-reviewed, long-term safety results ...

- New feature includes AI-driven emotion and language predictions for users in real-time, hands-free without the need for eye tracker or voice control NEW YORK--(BUSINESS WIRE)--Synchron, the ...

Synchron Inc, a rival to Elon Musk’s Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the company ...